scholarly article | Q13442814 |
P356 | DOI | 10.1002/EJI.1830260629 |
P698 | PubMed publication ID | 8647219 |
P2093 | author name string | Phipps RP | |
Gaspari AA | |||
Sempowski GD | |||
Chess P | |||
Gish J | |||
P2860 | cites work | Human keratinocytes regulate their expression of B7/BB-1 antigen by a unique, calcium-dependent mechanism | Q71691576 |
A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells | Q28187669 | ||
The CD40 antigen and its ligand | Q28286277 | ||
CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells | Q30442717 | ||
Calcium regulation of growth and differentiation of mouse epidermal cells in culture | Q34248695 | ||
CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40 | Q34721501 | ||
Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells | Q35609177 | ||
Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50 | Q35612157 | ||
Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. | Q36231002 | ||
Isolated human follicular dendritic cells display a unique antigenic phenotype | Q36356417 | ||
Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. | Q36361303 | ||
Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation | Q36361516 | ||
B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells | Q36362252 | ||
The biology of the human ligand for CD40. | Q40385754 | ||
Activation of human dendritic cells through CD40 cross-linking. | Q41440958 | ||
CD40 expression by human fibroblasts | Q41667845 | ||
Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis | Q41675873 | ||
Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen | Q41694124 | ||
Expression of functional CD40 by vascular endothelial cells | Q41981036 | ||
Nasopharyngeal carcinoma and lymphoinfiltration | Q42472272 | ||
Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes | Q42490090 | ||
Further characterization of surface membrane structures expressed on human basophils and mast cells. | Q50884011 | ||
Hybridization of oligo(dT) to RNA on nitrocellulose. | Q52603166 | ||
A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. | Q53548006 | ||
Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes | Q67543297 | ||
Synergistic interaction between interleukin 4 and anti-Bp50 (CDw40) revealed in a novel B cell restimulation assay | Q68832722 | ||
P433 | issue | 6 | |
P921 | main subject | keratinocyte | Q1473931 |
P304 | page(s) | 1371-1377 | |
P577 | publication date | 1996-06-01 | |
P1433 | published in | European Journal of Immunology | Q5412727 |
P1476 | title | Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism | |
P478 | volume | 26 |
Q77589706 | A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas |
Q36368842 | Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells |
Q33918960 | CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion |
Q77567235 | CD40 and epithelial cells: across the great divide |
Q42483615 | CD40 ligation inhibits trichilemmoma cell proliferation and induces IL-6 production |
Q43576662 | CD40-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I, ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors |
Q35788667 | CD40-CD40 ligand disruption does not prevent hyperoxia-induced injury |
Q34488528 | CD40-mediated amplification of local immunity by epithelial cells is impaired by HPV. |
Q34082784 | CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. |
Q41865370 | Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome. |
Q26852611 | Early Defensive Mechanisms against Human Papillomavirus Infection |
Q42503921 | Expression of CD23/CD21 and CD40/CD40 ligand in vernal keratoconjunctivitis |
Q35746676 | Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts |
Q34434772 | Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation |
Q40132375 | Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells. |
Q35671715 | Human models of inherited immunoglobulin class switch recombination and somatic hypermutation defects (hyper-IgM syndromes). |
Q78577592 | Melanocytes are potential immunocompetent cells: evidence from recognition of immunological characteristics of cultured human melanocytes |
Q60950662 | The Human Papillomavirus (HPV) E6 Oncoprotein Regulates CD40 Expression via the AT-Hook Transcription Factor AKNA |
Q33937074 | The platelet as an immune cell-CD40 ligand and transfusion immunomodulation |
Search more.